Olema Pharmaceuticals, Inc. (OLMA)

NASDAQ: OLMA · Real-Time Price · USD

14.59

-0.70 (-4.58%)

At close: Apr 28, 2026, 4:00 PM EDT

14.60

+0.01 (0.07%)

Pre-market: Apr 29, 2026, 6:38 AM EDT

Olema Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2018
Net Income	-162.45	-129.47	-96.66	-104.79	-71.1	Upgrade
Depreciation & Amortization	0.49	0.39	0.38	0.36	0.16	Upgrade
Loss (Gain) From Sale of Assets	-	0.01	0.11	-	-	Upgrade
Loss (Gain) From Sale of Investments	-	-	-	-	0.28	Upgrade
Stock-Based Compensation	17.59	22.58	17.26	18.83	15.91	Upgrade
Other Operating Activities	-5.12	-7.03	-4.23	0.51	1.22	Upgrade
Change in Accounts Payable	4.6	2.51	2.32	0.35	-0.68	Upgrade
Change in Other Net Operating Assets	-1.82	6.65	-2.91	2.67	3.51	Upgrade
Operating Cash Flow	-146.72	-104.35	-83.73	-82.07	-50.69	Upgrade
Capital Expenditures	-	-0.16	-	-0.36	-1.58	Upgrade
Sale of Property, Plant & Equipment	-	-	0.01	-	-	Upgrade
Investment in Securities	-155.76	-93.37	-4.87	91.84	-273.86	Upgrade
Investing Cash Flow	-155.76	-93.53	-4.85	91.48	-275.44	Upgrade
Long-Term Debt Issued	3	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	3	-	-	-	-	Upgrade
Issuance of Common Stock	227.92	275.48	133.42	0.48	1.39	Upgrade
Other Financing Activities	-19.62	-6.66	-	-	-	Upgrade
Financing Cash Flow	211.3	268.82	133.42	0.48	1.39	Upgrade
Net Cash Flow	-91.18	70.94	44.84	9.89	-324.74	Upgrade
Free Cash Flow	-146.72	-104.51	-83.73	-82.43	-52.27	Upgrade
Free Cash Flow Per Share	-1.69	-1.78	-1.85	-2.06	-1.32	Upgrade
Levered Free Cash Flow	-82.9	-42.7	-43.1	-41.64	-26.52	Upgrade
Unlevered Free Cash Flow	-82.9	-42.7	-43.1	-41.64	-26.52	Upgrade
Change in Working Capital	2.78	9.16	-0.59	3.02	2.83	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.